Desmopressin (DDAVP) was promptly administered in all patients with ADH deficiency [8–10, 13, 14], while glucocorticoid and thyroid hormone replacement therapy was established in patients with anterior pituitary dysfunction [15, 16]. Here, TG is linked to neurohypophyseal diabetes insipidus.